Skip to main content
. 2024 Dec 10;71:87–95. doi: 10.1016/j.euros.2024.11.005

Table 2.

Descriptive statistics for survivors and controls

Variable Controls (n = 327) Survivors (n= 109) p value
Age
 Min, max 72.8, 88.2 72.9, 86.9
 Mean (SD) 78.2 (3.2) 78.3 (3.2) 0.350 a
Educational attainment (n = 327 + 108), n (%)
 Primary school 63 (19.3) 21 (19.4) 0.999 b
 High school 75 (22.9) 24 (22.2)
 Vocational education 63 (19.3) 21 (19.4)
 College/university 126 (38.5) 42 (38.9)
Cohabitant status (n = 325 + 109), n (%)
 Living alone 63 (19.4) 18 (16.5) 0.496 c
 Living with others 262 (80.6) 91 (83.5)
Comorbidities (self-reported; n = 277 + 107)
 Min, max 0, 8 0, 7
 Mean (SD) 1.6 (1.5) 1.2 (1.4) 0.011
CCI (n = 109)
 Min, max NA 1.0 (1.3) a,*
 Mean (SD) NA 0, 6
Primary treatment (n = 109), n (%)
 RARP NA 67 (61.5) NA
 EBRT NA 42 (38.5)
 Adjuvant ADT NA 38 (90.5 d) NA

ADT = androgen deprivation therapy; CCI = Charlson Comorbidity Index; EBRT = external beam radiotherapy; NA = not applicable; RARP = robotic-assisted radical prostatectomy; SD = standard deviation.

*

Significance level p < 0.05.

a

p value from linear mixed model adjusting for within-pair correlations.

b

p-value χ2 test.

c

p value from hierarchical multinomial regression model adjusting for within-pair correlations.

d

Percentage of EBRT.